Steven Globerman

Director, Center for International Business, Western Washington University

Mr. Steven Globerman is the Kaiser Professor of International Business and Director of the Center for International Business at Western Washington University, and Senior Fellow at the Fraser Institute. Previously, he held tenured appointments at Simon Fraser University and York University and has been a visiting professor at the University of California, University of British Columbia, Stockholm School of Economics, Copenhagen School of Business, and the Helsinki School of Economics.

He has published more than 150 articles and monographs and is the author of the book The Impacts of 9/11 on Canada-U.S. Trade as well as a textbook on international business management. In the early 1990s, he was responsible for coordinating Fraser Institute research on the North American Free Trade Agreement.

In addition, Mr. Globerman has served as a researcher for two Canadian Royal Commissions on the economy as well as a research advisor to Investment Canada on the subject of foreign direct investment. He has also hosted management seminars for policymakers across North America and Asia.

Mr. Globerman was a founding member of the Association for Cultural Economics and is currently a member of the American and Canadian Economics Associations, the Academy of International Business, and the Academy of Management.

He earned his BA in economics from Brooklyn College, his MA from the University of California, Los Angeles, and his PhD from New York University.

Recent Research by Steven Globerman

— Oct 14, 2016
Printer-friendly version
Intellectual Property Rights and the Promotion of Biologics, Medical Devices, and Trade in Pharmaceuticals

Intellectual Property Rights and the Promotion of Biologics, Medical Devices, and Trade in Pharmaceuticals finds that if patent protections for drugs and medical devices were strengthened around the world, it could ultimately lower costs in Canada and help save lives by spurring innovation. And until stronger patent protections are established around the world, developed countries should streamline cross-border regulations for pharmaceuticals and medical devices, which would help reduce prices for patients and health-care systems.

— May 25, 2016
Printer-friendly version
Technological Change and Its Implications for Regulating Canada's Television Broadcasting Sector

Technological Change and Its Implications for Regulating Canada’s Television Broadcasting Sector finds that the low-cost methods of creating and distributing broadcasting content means that the Canadian Radio-television and Telecommunications Commission’s (CRTC) traditional policies to protect and subsidize Canadian content are increasingly unsustainable.

— Jan 21, 2016
Printer-friendly version
Select Cost Sharing in Universal Health Care Countries

Select Cost Sharing in Universal Health Care Countries examines the utilization of health-care user fees — for access to hospitals, general practitioners or specialists — in other countries which, like Canada, have accessible and high-performing universal health care. It finds that Canada remains one of the few universal access countries that doesn’t require patients to participate in paying for care through some form of cost sharing.